Skip to content

Clinical trials

Phase 2 Overweight trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Phase: Phase 2 Country / region: Australia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20171
20221
20231
20244
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting3
Not yet recruiting3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Biomed Industries, Inc.2
Eli Lilly and Company2
Zafgen, Inc.2
Amgen1
Boehringer Ingelheim1
Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.1
Immunwork, Inc.1
Kailera1
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity16
Overweight16
Diabetes Mellitus, Type 23
Weight Loss2
Alcoholism1
Body Weight1
Body Weight Changes1
Diabetes Mellitus1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.